Influence of food on the pharmacokinetics of apricitabine, a novel deoxycytidine analogue reverse transcriptase inhibitor

By Holdich Tom   Sawyer James  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 12, 2008-08 ,pp. : 2021-2025

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics of Single Oral Doses of Apricitabine, a Novel Deoxycytidine Analogue Reverse Transcriptase Inhibitor, in Healthy Volunteers

By Holdich Tom  

Clinical Drug Investigation, Vol. 26, Iss. 5, 2006-01 ,pp. : 279-286

Adis International

Access to resources Recommend Favorite

The Role of Non-Nucleoside Reverse Transcriptase Inhibitors in Children with HIV-1 Infection

By Maddocks S.   Dwyer D.  

Pediatric Drugs, Vol. 3, Iss. 9, 2001-01 ,pp. : 681-702

Adis International

Access to resources Recommend Favorite

Multiple-Dose Pharmacokinetics and Safety of Bevirimat, a Novel Inhibitor of HIV Maturation, in Healthy Volunteers

By Martin David E.  

Clinical Pharmacokinetics, Vol. 46, Iss. 7, 2007-01 ,pp. : 589-598

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and safety of escalating single and repeat oral doses of GW420867X, a novel non-nucleoside reverse transcriptase inhibitor

By Moore K.H.P.   Cass L.M.   Dallow N.   Hardman T.C.   Jones A.   Boyce M.   Prince W.T.  

European Journal of Clinical Pharmacology, Vol. 56, Iss. 11, 2001-01 ,pp. : 805-811

Springer Publishing Company

Access to resources Recommend Favorite